W. James

发表

Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes

Arya M. Sharma, L. Køber, L. V. Van Gaal, 2013, Diabetes Care.

International Association for the Study of Obesity and China

W. James, 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial

V. Gebski, C. Torp‐Pedersen, A. Maggioni, 2014, International Journal of Obesity.

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

C. Torp‐Pedersen, A. Maggioni, L. V. Van Gaal, 2012, Diabetes, obesity & metabolism.

Blood pressure changes associated with sibutramine and weight management – an analysis from the 6‐week lead‐in period of the sibutramine cardiovascular outcomes trial (SCOUT) *

C. Torp‐Pedersen, A. Maggioni, L. V. Van Gaal, 2009, Diabetes, obesity & metabolism.

Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

Arya M. Sharma, B. Brendorp, L. Køber, 2009, Metabolism: clinical and experimental.

Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial.

C. Torp‐Pedersen, C. Torp-Pedersen, I. Caterson, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients

W. James, 2005 .

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

G. Williams, M. Lean, P. Kopelman, 2000, International Journal of Obesity.

Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals

Arya M. Sharma, A. Maggioni, L. V. Van Gaal, 2013, PloS one.

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

C. Torp‐Pedersen, P. Weeke, A. Maggioni, 2012, Diabetologia.

Obesity in Malaysia

K. Yusoff, T. Lim, M. Ismail, 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Physical activity and its impact on health outcomes. Paper 2: prevention of unhealthy weight gain and obesity by physical activity: an analysis of the evidence

W. James, J. Erlichman, A. L. Kerbey, 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Leisure‐time physical activity alone may not be a sufficient public health approach to prevent obesity – a focus on China

A. Bauman, M. Allman-Farinelli, W. James, 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease

V. Gebski, R. Seimon, L. Ivers, 2014, International Journal of Obesity.

Physical activity and its impact on health outcomes. Paper 1: the impact of physical activity on cardiovascular disease and all‐cause mortality: an historical perspective

W. James, J. Erlichman, A. L. Kerbey, 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries.

L. Køber, S. Z. Abildstrøm, C. Torp-Pedersen, 2008, European heart journal.

Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta‐analysis

T. Lobstein, R. Leach, K. Gurusamy, 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Weight and blood pressure response to weight management and sibutramine in diabetic and non‐diabetic high‐risk patients: an analysis from the 6‐week lead‐in period of the sibutramine cardiovascular outcomes (SCOUT) trial

C. Torp‐Pedersen, A. Maggioni, L. V. Van Gaal, 2010, Diabetes, obesity & metabolism.

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

S. Toubro, A. Astrup, S. Rössner, 2001, International Journal of Obesity.

Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population

A. Zabetian, D. Khalili, P. Sarbakhsh, 2009, International Journal of Obesity.

Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial).

A. Astrup, S. Rössner, W. Saris, 2003, The American journal of clinical nutrition.

WHO recognition of the global obesity epidemic

W. James, W P T James, W. James, 2008, International Journal of Obesity.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Arya M. Sharma, C. Torp‐Pedersen, W. James, 2010, The New England journal of medicine.

Increasing levels of excess weight among children in England

T J Cole, T. Cole, T. Lobstein, 2003, International Journal of Obesity.

Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries.

L. Køber, C. Torp-Pedersen, W. James, 2008, European heart journal.